These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3494820)

  • 1. Establishment of interleukin 2 dependent cytotoxic T lymphocyte cell line specific for autologous brain tumor and its intracranial administration for therapy of the tumor.
    Kitahara T; Watanabe O; Yamaura A; Makino H; Watanabe T; Suzuki G; Okumura K
    J Neurooncol; 1987; 4(4):329-36. PubMed ID: 3494820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of human glioma-specific cytotoxic T-lymphocyte lines by autologous tumor stimulation and interleukin 2.
    Miyatake S; Handa H; Yamashita J; Yamasaki T; Ueda M; Namba Y; Hanaoka M
    J Neurooncol; 1986; 4(1):55-64. PubMed ID: 3489081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific adoptive immunotherapy of malignant glioma with long-term cytotoxic T lymphocyte line expanded in T-cell growth factor. Experimental study and future prospects.
    Yamasaki T; Handa H; Yamashita J; Watanabe Y; Namba Y; Hanaoka M
    Neurosurg Rev; 1984; 7(1):37-54. PubMed ID: 6611523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Adoptive immunotherapy in patients with malignant glioma].
    Yoshida S; Takai N; Saito T; Tanaka R
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1930-2. PubMed ID: 3496052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local administration of autologous lymphokine-activated killer cells and recombinant interleukin 2 to patients with malignant brain tumors.
    Yoshida S; Tanaka R; Takai N; Ono K
    Cancer Res; 1988 Sep; 48(17):5011-6. PubMed ID: 3261631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of specific cytotoxic T lymphocytes against autologous brain tumor by crossreactive allo-tumor cell stimulation.
    Saitoh S; Kurisaka M; Mori K; Maeda N; Fujimoto S
    Jpn J Cancer Res; 1997 Mar; 88(3):289-95. PubMed ID: 9140114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor lysate and IL-18 loaded dendritic cells elicits Th1 response, tumor-specific CD8+ cytotoxic T cells in patients with malignant glioma.
    Yamanaka R; Honma J; Tsuchiya N; Yajima N; Kobayashi T; Tanaka R
    J Neurooncol; 2005 Apr; 72(2):107-13. PubMed ID: 15925989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary clinical trial of immunotherapy for malignant glioma.
    Ingram M; Shelden CH; Jacques S; Skillen RG; Bradley WG; Techy GB; Freshwater DB; Abts RM; Rand RW
    J Biol Response Mod; 1987 Oct; 6(5):489-98. PubMed ID: 3316510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of glioma with intratumoral instillation of autologous lymphocytes.
    Bhagwati SN
    Childs Nerv Syst; 1989 Feb; 5(1):38-40. PubMed ID: 2702675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 2-activated cytotoxic lymphocytes in cancer therapy.
    Grimm EA; Jacobs SK; Lanza LA; Melin G; Roth JA; Wilson DJ
    Symp Fundam Cancer Res; 1986; 38():209-19. PubMed ID: 3489259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of recurrent glioma with intracavitary alloreactive cytotoxic T lymphocytes and interleukin-2.
    Kruse CA; Cepeda L; Owens B; Johnson SD; Stears J; Lillehei KO
    Cancer Immunol Immunother; 1997 Oct; 45(2):77-87. PubMed ID: 9390198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focused ultrasound-induced blood-brain barrier opening to enhance interleukin-12 delivery for brain tumor immunotherapy: a preclinical feasibility study.
    Chen PY; Hsieh HY; Huang CY; Lin CY; Wei KC; Liu HL
    J Transl Med; 2015; 13():93. PubMed ID: 25784614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Induction of LAK cells and CTL in patients with brain tumor and research of its clinical application].
    Moriki A
    Nihon Geka Hokan; 1989 Jan; 58(1):107-18. PubMed ID: 2802908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratumoral LAK cell and interleukin-2 therapy of human gliomas.
    Barba D; Saris SC; Holder C; Rosenberg SA; Oldfield EH
    J Neurosurg; 1989 Feb; 70(2):175-82. PubMed ID: 2643685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific adoptive immunotherapy with tumor-specific cytotoxic T-lymphocyte clone for murine malignant gliomas.
    Yamasaki T; Handa H; Yamashita J; Watanabe Y; Namba Y; Hanaoka M
    Cancer Res; 1984 May; 44(5):1776-83. PubMed ID: 6608988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of interleukin 2 and various effector cell populations in adoptive immunotherapy of 9L rat gliosarcoma: allogeneic cytotoxic T lymphocytes prevent tumor take.
    Kruse CA; Lillehei KO; Mitchell DH; Kleinschmidt-DeMasters B; Bellgrau D
    Proc Natl Acad Sci U S A; 1990 Dec; 87(24):9577-81. PubMed ID: 2263613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical application of adoptive immunotherapy by cytotoxic T lymphocytes induced from tumor-infiltrating lymphocytes].
    Yamaue H; Tanimura H; Tsunoda T; Iwahashi M; Tani M; Inoue M; Tamai M
    Nihon Gan Chiryo Gakkai Shi; 1990 May; 25(5):978-89. PubMed ID: 2391445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adoptive immunotherapy of malignant glioma using tumor-sensitized T lymphocytes.
    Merchant RE; Baldwin NG; Rice CD; Bear HD
    Neurol Res; 1997 Apr; 19(2):145-52. PubMed ID: 9175143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Basic and clinical study of adoptive immunotherapy using cytotoxic T lymphocyte (CTL) against cancers].
    Kitsukawa K
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1448-54. PubMed ID: 2543306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glioma-specific cytotoxic T cells can be effectively induced by subcutaneous vaccination of irradiated wild-type tumor cells without artificial cytokine production.
    Iwadate Y; Yamaura A; Sakiyama S; Sato Y; Tagawa M
    Int J Oncol; 2003 Aug; 23(2):483-8. PubMed ID: 12851699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.